Dr Stephen Harrison, chairman for both Pinnacle Clinical Research and Summit Clinical Research, San Antonio ... biotechnology and generics sectors of ...
News
- Positive Phase III results for Madrigal's resmetirom in NASH published - The Pharma Letter
- Pre-diabetes gets its due: New $1.2 million award aimed at early intervention and treatment
A physician-scientist at The University of Texas Health Science Center at San Antonio receives award to develop measures to halt progression of ...
- Fact Check Team: Some employers are ditching THIS major job requirement - WOAI
WOAI NBC News Channel 4 San Antonio provides local news, weather forecasts, traffic updates, investigations, and items of interest in the ...
- Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH ... - BioSpace
Stephen Harrison, M.D., Chairman for both Pinnacle Clinical Research and Summit Clinical Research, San Antonio ... Biotech Bay · Biotech Beach ...
- Sana Biotechnology raising $165M through public offering - Puget Sound Business Journal
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Seattle-based biotech Sana Biotechnology Inc. (Nasdaq: SANA) is ...